GlassScriptPhysician profile
Tu-Hi Hong
NPI 1912089939
$3,197.75
in general payments reported to CMS, 2019-2025
20 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $314 · 2021: $310 · 2022: $525 · 2023: $495 · 2024: $445 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.50 |
| Education | $169.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $938.01 | 2022-2025 | Erleada |
| Astellas Pharma US INC | $851.35 | 2019-2024 | Myrbetriq |
| Abbvie INC. | $232.80 | 2019-2025 | |
| Antares Pharma, INC. | $222.27 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Karl Storz Endoscopy-America | $162.82 | 2019-2024 | N.A. |
| Boston Scientific Corporation | $142.53 | 2019-2022 | |
| Pfizer INC. | $114.61 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $95.01 | 2023-2025 | Gemtesa |
| Halozyme INC | $73.72 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.23 | 2020-2025 | |
| Urovant Sciences INC | $64.00 | 2022 | |
| Teleflex LLC | $41.60 | 2023-2024 | Urolift |
| Coloplast Corp | $39.47 | 2020-2024 | |
| Procept Biorobotics Corporation | $32.53 | 2021-2022 | |
| Olympus America INC. | $24.74 | 2024 | Itind System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $22.83 | 2024 | Trelstar |
| Intuitive Surgical, INC. | $22.32 | 2024 | |
| Dendreon Pharmaceuticals LLC | $16.54 | 2019 | |
| Urogen Pharma, INC. | $16.53 | 2020 | |
| Myovant Sciences INC. | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tu-Hi Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.